Raadr Inc (PK)【RDAR】株式ニュース

A capital-raising tool RDAR can actually execute — and why it works where a preferred dividend stalled

Back in August 2025, the company floated a preferred share dividend. It surfaced, then went quiet — no declaration, no record date. I want to lay out, on-topic and concretely, why a preferred dividend is hard to make work for an OTC issuer, and what the cleaner, executable alternative is. Nothing exotic, nothing outside what a Reg A company can actually do.

First, why the preferred dividend likely stalled. For a dividend to do anything beyond distribute value, the distributed security has to be hard to source synthetically. But any DTC-eligible, fungible preferred gets handled by the settlement system the ordinary way — brokers credit and net it like any other fungible security. To make it non-fungible enough to matter, you'd need a non-DTC or restricted instrument, which an OTC issuer generally can't distribute without risking a DTC chill. That's the box: the version that would matter is the version you can't issue, and the version you can issue doesn't move the needle. Competent counsel would have flagged exactly that — a plausible reason the idea was floated and then paused.

Now the tool that doesn't hit that wall: a rights offering.

A rights offering distributes to shareholders of record the right to buy additional shares, usually at a discount, over a subscription period. Its purpose is raising capital from the existing base rather than through dilutive third-party financing — relevant for any company funding acquisitions and growth cleanly.

The mechanics are where it differs from the dividend. A rights offering is processed through DTC's standard Automated Subscription Offer Program (ASOP), with the transfer agent as subscription agent. When holders exercise, rights are surrendered through DTC — and a broker can only surrender rights it actually holds in its own DTC position. The transfer agent then reconciles total exercises against the finite number of rights issued before releasing new shares.

That reconciliation is routine — every rights offering works this way. But it forces alignment at the surrender step, the one point where a position has to be backed by real rights at DTC. A broker can't exercise more rights than its actual DTC position supports. Whatever a broker's customers believe they hold, the broker can only pass through what it can back, and any shortfall is the broker's to resolve, not the issuer's.

So a rights offering does, through standard accepted mechanics, what the preferred dividend couldn't: it forces reconciliation at a point that can't be papered over, while raising real capital — and without any non-standard instrument that would risk a DTC chill.

On feasibility for a Reg A issuer specifically: this is executable. Reg A companies can and do conduct rights offerings — Teton Advisors, an OTC Reg A issuer, did one with standard DTC/ASOP processing. The one added step versus a fully-reporting company is that RDAR would need to qualify the rights and underlying shares through a new or amended Form 1-A before exercise — a normal SEC qualification process, not a barrier, just a timeline. Already-DTC-eligible common shares otherwise process through ASOP the standard way.

To be precise about what I'm and am not claiming: I'm not asserting anything specific about RDAR's share structure. I'm explaining why one instrument (preferred dividend) is hard to make work for an OTC issuer, why another (rights offering) is both executable and has a useful byproduct that follows from how DTC's ASOP already operates, and what the Reg A path to it looks like. Whether and how to use it is management's call with counsel and the transfer agent.

For a company pursuing acquisitions and growth, a rights offering is a legitimate, shareholder-friendly capital-raising tool — and notably more executable than the preferred dividend floated last year.

Mechanics and precedent are verifiable in public sources: DTC Operational Arrangements, the DTC ASOP Agent User Guide, Regulation A (17 CFR 230.251 et seq.), and the Teton Advisors Form 1-A rights offering.